|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses - loans | |||||
| Provision for credit losses | |||||
| Depreciation | |||||
| Amortization of intangibles | |||||
| Net amortization of security discounts/premiums | |||||
| Noncash operating lease expense | |||||
| Amortization of finance lease right of use asset | |||||
| Loss (gain) on sales of investment securities | |||||
| Amortization of finance lease right-of-use asset | |||||
| Earnings on cash surrender value of life insurance | |||||
| Mortgage loans originated for sale | |||||
| Proceeds from sales of mortgage loans originated for sale | |||||
| Gain on sale of mortgage loans | |||||
| SBA loans originated for sale | |||||
| Proceeds from sales of SBA loans originated for sale | |||||
| Gain on sale of SBA loans | |||||
| Gain on sale of property, plant, and equipment | |||||
| Loss/(gain) on sale of foreclosed assets, net | |||||
| Write-off of bank premises and equipment held for sale | |||||
| Discount on subordinated debt | |||||
| Stock compensation expense | |||||
| Change in deferred income taxes | |||||
| Fair value adjustment on equity investments | |||||
| Increase in accrued interest receivable | |||||
| (Increase)/decrease in other assets | |||||
| (Decrease)/increase in accrued interest payable | |||||
| Increase/(decrease) in operating lease liability | |||||
| (Decrease)/increase in other liabilities | |||||
| Net Cash Provided By Operating Activities | |||||
| Investing Activities: | |||||
| Proceeds from the sale of available-for-sale securities | |||||
| Proceeds from the maturity or call of available-for-sale securities | |||||
| Purchases of available-for-sale securities | |||||
| Proceeds from the maturity or call of held-to-maturity securities | |||||
| Purchases of held-to-maturity securities | |||||
| Stock dividends received on FHLB and other bank stock | |||||
| (Purchases)/reduction of restricted investment in bank stock | |||||
| Net cash received/(paid) from acquisitions | |||||
| Net increase in loans | |||||
| Purchases of bank premises and equipment | |||||
| Proceeds from the sale of premises and equipment | |||||
| Proceeds from the sale of foreclosed assets | |||||
| Proceeds from bank-owned life insurance | |||||
| Earnings on bank-owned life insurance | |||||
| Net change in investments in tax credits and other partnerships | |||||
| Net cash paid on branch sale | |||||
| Net Cash Provided by (Used in) Investing Activities | |||||
| Financing Activities: | |||||
| Net (decrease)/increase in deposits | |||||
| Common stock dividends paid | |||||
| Proceeds from Employee and Director Stock Purchase Plan stock issuance | |||||
| Treasury stock purchased | |||||
| Riverview restricted stock | |||||
| Net change in finance lease liability | |||||
| Net change in short-term borrowings | |||||
| Proceeds from short-term borrowings | |||||
| Repayment of short-term borrowings | |||||
| Total net change in short-term borrowings | |||||
| Long-term debt repayment | |||||
| Proceeds from long-term debt | |||||
| Subordinated debt redemption | |||||
| Exercise of stock options | |||||
| Net Cash (Used in)/Provided by Financing Activities | |||||
| Net increase/(decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental Disclosures of Cash Flow Information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental Noncash Disclosures: | |||||
| Recognition of operating lease right-of-use assets | |||||
| Recognition of operating lease liabilities | |||||
| Obsolete Riverview asset write-off | |||||
| Loans transferred to foreclosed assets held-for-sale | |||||
| Common Stock issued to Riverview Shareholders | |||||
| Total common Stock issued to Riverview Shareholders | |||||
| Carrying value of assets sold in branch sale | |||||
| Liabilities assigned in branch sale | |||||
| Fair value of assets acquired in business combination, excluding cash | |||||
| Total fair value of assets acquired in business combination, excluding cash | |||||
| Goodwill recorded | |||||
| Fair value of liabilities assumed in business combination | |||||
| Total fair value of liabilities assumed in business combination | |||||
| Fair value of shares issued in business combination | |||||
Loading...